Accendra Health SEC filings

Filter: All · 8-K · 10-Q · 10-K · Form 4

8-KOct. 30, 2026, 4:50 p.m. ETView on SEC.gov Our explainer
Delisting notice / failure to meet listing standard · Regulation FD disclosure · Financial statements and exhibits
AI summary, unreviewedAccendra Health Receives NYSE Continued Listing Notice Over Market Capitalization and Stockholders' Equity Below $50.0 Million
8-KOct. 9, 2026, 4:10 p.m. ETView on SEC.gov
Delisting notice / failure to meet listing standard · Regulation FD disclosure · Financial statements and exhibits
SCHEDULE 13GOct. 7, 2026, 11:28 a.m. ETView on SEC.gov
4Oct. 6, 2026, 8:15 p.m. ETView on SEC.gov
8-K/ASept. 28, 2026, 5:06 p.m. ETView on SEC.gov
Departure/appointment of directors or officers · Financial statements and exhibits
4Sept. 24, 2026, 4:31 p.m. ETView on SEC.gov
8-KSept. 17, 2026, 6:35 a.m. ETView on SEC.gov
Departure/appointment of directors or officers · Regulation FD disclosure · Other events · Financial statements and exhibits
8-KAug. 17, 2026, 6:42 a.m. ETView on SEC.gov
Regulation FD disclosure · Financial statements and exhibits
8-KAug. 10, 2026, 4:15 p.m. ETView on SEC.gov
Entry into a material definitive agreement · Material modification of security holders' rights · Amendments to articles or bylaws; fiscal year change · Regulation FD disclosure · Financial statements and exhibits
10-QAug. 10, 2026, 11:15 a.m. ETView on SEC.gov
8-KAug. 10, 2026, 6:50 a.m. ETView on SEC.gov
Results of operations and financial condition · Regulation FD disclosure · Financial statements and exhibits
8-KAug. 10, 2026, 6:36 a.m. ETView on SEC.gov
Departure/appointment of directors or officers · Regulation FD disclosure · Financial statements and exhibits